Literature DB >> 2680545

A christening party outbreak of haemorrhagic colitis and haemolytic uraemic syndrome associated with Escherichia coli O 157.H7.

R L Salmon1, I D Farrell, J G Hutchison, D J Coleman, R J Gross, N K Fry, B Rowe, S R Palmer.   

Abstract

A point source outbreak of haemorrhagic colitis due to Escherichia coli O 157.H7 producing verocytotoxin (VT), took place following a christening party in Birmingham in June 1987. Twenty-six people were affected, six were admitted to hospital and one developed haemolytic uraemic syndrome: there were no deaths. VT + E. coli O 157.H7 was isolated from 13 (57%) of 23 faecal specimens from affected people and from 3 (9%) of 33 specimens from asymptomatic people. Free VT was detected in the faeces of one further asymptomatic person. Illness was associated with eating turkey-roll sandwiches (P less than 0.001) suggesting that cold meats might be an important source of infection.

Entities:  

Mesh:

Year:  1989        PMID: 2680545      PMCID: PMC2249521          DOI: 10.1017/s0950268800030600

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  13 in total

1.  Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands.

Authors:  C M Taylor; R H White; M H Winterborn; B Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-07

2.  Haemorrhagic colitis and verotoxin-producing Escherichia coli O157 in Belgium.

Authors:  G Robaeys; I Surmont; P Lemmens; G Coremans; G Vantrappen; J Vandepitte
Journal:  Lancet       Date:  1987-06-27       Impact factor: 79.321

3.  A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home.

Authors:  A O Carter; A A Borczyk; J A Carlson; B Harvey; J C Hockin; M A Karmali; C Krishnan; D A Korn; H Lior
Journal:  N Engl J Med       Date:  1987-12-10       Impact factor: 91.245

4.  First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK.

Authors:  G M Morgan; C Newman; S R Palmer; J B Allen; W Shepherd; A M Rampling; R E Warren; R J Gross; S M Scotland; H R Smith
Journal:  Epidemiol Infect       Date:  1988-08       Impact factor: 2.451

5.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

Authors:  C H Pai; R Gordon; H V Sims; L E Bryan
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

6.  Heterogeneity of Escherichia coli phages encoding Vero cytotoxins: comparison of cloned sequences determining VT1 and VT2 and development of specific gene probes.

Authors:  G A Willshaw; H R Smith; S M Scotland; A M Field; B Rowe
Journal:  J Gen Microbiol       Date:  1987-05

7.  Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales.

Authors:  H R Smith; B Rowe; R J Gross; N K Fry; S M Scotland
Journal:  Lancet       Date:  1987-05-09       Impact factor: 79.321

8.  Vero cytotoxin-producing strains of Escherichia coli from children with haemolytic uraemic syndrome and their detection by specific DNA probes.

Authors:  S M Scotland; B Rowe; H R Smith; G A Willshaw; R J Gross
Journal:  J Med Microbiol       Date:  1988-04       Impact factor: 2.472

9.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

10.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

View more
  14 in total

1.  Escherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.

Authors:  P C Rowe
Journal:  Can J Infect Dis       Date:  1995-03

2.  Verocytotoxin producing Escherichia coli.

Authors:  M G Brook; B A Bannister
Journal:  BMJ       Date:  1991-10-05

Review 3.  Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae.

Authors:  Jessica Keithlin; Jan Sargeant; M Kate Thomas; Aamir Fazil
Journal:  Foodborne Pathog Dis       Date:  2013-11-27       Impact factor: 3.171

4.  Surgical complications of the haemolytic uraemic syndrome.

Authors:  V V Varjavandi; W D Ford; K F Juredini; P H Henning; R G Power; K E Little; R B Davey
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

5.  Culture negative cytotoxin positive stools in community acquired diarrhoea.

Authors:  D Burke; B J al Jumaili; H al Mardini; C O Record
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

6.  Prevalence and characteristics of human and bovine verotoxigenic Escherichia coli strains isolated in Galicia (north-western Spain).

Authors:  M Blanco; J E Blanco; J Blanco; E A Gonzalez; M P Alonso; H Maas; W H Jansen
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

7.  Prevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals.

Authors:  L Beutin; D Geier; H Steinrück; S Zimmermann; F Scheutz
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

8.  Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man.

Authors:  P A Chapman; C A Siddons; D J Wright; P Norman; J Fox; E Crick
Journal:  Epidemiol Infect       Date:  1993-12       Impact factor: 2.451

9.  Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigators.

Authors:  P C Rowe; E Orrbine; H Lior; G A Wells; P N McLaine
Journal:  Epidemiol Infect       Date:  1993-02       Impact factor: 2.451

10.  Prevalence of bovine verotoxin-producing Escherichia coli in Argentina.

Authors:  M E Sanz; M R Viñas; A E Parma
Journal:  Eur J Epidemiol       Date:  1998-06       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.